TXG Annual CFI
$133.49 M
+$484.38 M+138.04%
31 December 2023
Summary:
As of January 22, 2025, TXG annual cash flow from investing activities is $133.49 million, with the most recent change of +$484.38 million (+138.04%) on December 31, 2023. During the last 3 years, it has risen by +$171.89 million (+447.69%). TXG annual CFI is now at all-time high.TXG Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Quarterly CFI
-$3.62 M
-$15.56 M-130.28%
30 September 2024
Summary:
As of January 22, 2025, TXG quarterly cash flow from investing activities is -$3.62 million, with the most recent change of -$15.56 million (-130.28%) on September 30, 2024. Over the past year, it has dropped by -$8.52 million (-173.84%). TXG quarterly CFI is now -103.02% below its all-time high of $119.96 million, reached on March 31, 2023.TXG Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG TTM CFI
$32.06 M
-$8.52 M-20.99%
30 September 2024
Summary:
As of January 22, 2025, TXG TTM cash flow from investing activities is $32.06 million, with the most recent change of -$8.52 million (-20.99%) on September 30, 2024. Over the past year, it has dropped by -$55.16 million (-63.24%). TXG TTM CFI is now -75.98% below its all-time high of $133.49 million, reached on December 31, 2023.TXG TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +138.0% | -173.8% | -63.2% |
| 3 y3 years | +447.7% | +86.9% | +130.0% |
| 5 y5 years | +2089.8% | +45.0% | +175.0% |
TXG Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +138.0% | -103.0% | +98.6% | -76.0% | +109.1% |
| 5 y | 5-year | at high | +138.0% | -103.0% | +98.6% | -76.0% | +109.1% |
| alltime | all time | at high | +138.0% | -103.0% | +98.6% | -76.0% | +109.1% |
10x Genomics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.62 M(-130.3%) | $32.06 M(-21.0%) |
| June 2024 | - | $11.95 M(+12.4%) | $40.58 M(+67.9%) |
| Mar 2024 | - | $10.63 M(-18.8%) | $24.17 M(-81.9%) |
| Dec 2023 | $133.49 M(-138.0%) | $13.10 M(+167.3%) | $133.49 M(+53.0%) |
| Sept 2023 | - | $4.90 M(-209.8%) | $87.22 M(+75.5%) |
| June 2023 | - | -$4.46 M(-103.7%) | $49.69 M(+86.6%) |
| Mar 2023 | - | $119.96 M(-461.6%) | $26.63 M(-107.6%) |
| Dec 2022 | -$350.89 M(+228.8%) | -$33.17 M(+1.7%) | -$350.89 M(+1.6%) |
| Sept 2022 | - | -$32.63 M(+18.5%) | -$345.33 M(+3.7%) |
| June 2022 | - | -$27.53 M(-89.3%) | -$332.93 M(+4.1%) |
| Mar 2022 | - | -$257.56 M(+832.6%) | -$319.97 M(+199.8%) |
| Dec 2021 | -$106.73 M | -$27.62 M(+36.5%) | -$106.73 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$20.23 M(+38.8%) | -$101.38 M(+22.9%) |
| June 2021 | - | -$14.57 M(-67.1%) | -$82.46 M(+10.5%) |
| Mar 2021 | - | -$44.32 M(+99.0%) | -$74.63 M(+94.4%) |
| Dec 2020 | -$38.39 M(-10.2%) | -$22.27 M(+1599.7%) | -$38.39 M(+69.1%) |
| Sept 2020 | - | -$1.31 M(-80.6%) | -$22.71 M(-35.3%) |
| June 2020 | - | -$6.74 M(-16.6%) | -$35.08 M(-15.4%) |
| Mar 2020 | - | -$8.08 M(+22.8%) | -$41.48 M(-3.0%) |
| Dec 2019 | -$42.77 M(+537.5%) | -$6.58 M(-51.9%) | -$42.77 M(+18.2%) |
| Sept 2019 | - | -$13.68 M(+4.1%) | -$36.19 M(+60.8%) |
| June 2019 | - | -$13.14 M(+40.3%) | -$22.51 M(+140.3%) |
| Mar 2019 | - | -$9.37 M | -$9.37 M |
| Dec 2018 | -$6.71 M(+78.6%) | - | - |
| Dec 2017 | -$3.76 M | - | - |
FAQ
- What is 10x Genomics annual cash flow from investing activities?
- What is the all time high annual CFI for 10x Genomics?
- What is 10x Genomics annual CFI year-on-year change?
- What is 10x Genomics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for 10x Genomics?
- What is 10x Genomics quarterly CFI year-on-year change?
- What is 10x Genomics TTM cash flow from investing activities?
- What is the all time high TTM CFI for 10x Genomics?
- What is 10x Genomics TTM CFI year-on-year change?
What is 10x Genomics annual cash flow from investing activities?
The current annual CFI of TXG is $133.49 M
What is the all time high annual CFI for 10x Genomics?
10x Genomics all-time high annual cash flow from investing activities is $133.49 M
What is 10x Genomics annual CFI year-on-year change?
Over the past year, TXG annual cash flow from investing activities has changed by +$484.38 M (+138.04%)
What is 10x Genomics quarterly cash flow from investing activities?
The current quarterly CFI of TXG is -$3.62 M
What is the all time high quarterly CFI for 10x Genomics?
10x Genomics all-time high quarterly cash flow from investing activities is $119.96 M
What is 10x Genomics quarterly CFI year-on-year change?
Over the past year, TXG quarterly cash flow from investing activities has changed by -$8.52 M (-173.84%)
What is 10x Genomics TTM cash flow from investing activities?
The current TTM CFI of TXG is $32.06 M
What is the all time high TTM CFI for 10x Genomics?
10x Genomics all-time high TTM cash flow from investing activities is $133.49 M
What is 10x Genomics TTM CFI year-on-year change?
Over the past year, TXG TTM cash flow from investing activities has changed by -$55.16 M (-63.24%)